HOUSE CONCURRENT RESOLUTION NO. 3001
(By Mr. Speaker, Mr. Kiss, and Delegates Trump, Boggs, Brown,
Campbell, Cann, Crosier, DeLong, Ennis, Fleischauer, Foster,
Hartman, Houston, Hrutkay, Kominar, Leach, Mahan, Manuel,
Martin, Michael, Morgan, Palumbo, Perdue, Perry, Pethtel, Pino,
Poling, Shaver, Spencer, Staton, Stemple, Susman, Swartzmiller,
R.M. Thompson, Varner, Warner, Webster, H. White, Williams and
Yost)
Authorizing the adoption and implementation of the use or
reference of the Federal Supply Schedule ("FSS") to establish
a benchmark for prescription drug prices for the negotiation
and purchase of brand name drugs by the State of West
Virginia; and further, authorizing the West Virginia
Pharmaceutical Cost Management Council to implement the
strategic plan established in the Reference Pricing Report
submitted on September 10, 2004, to the Joint Committee on
Government and Finance in accordance with the provisions of
article three-c, chapter five-a of the code of West Virginia,
1931, as amended; and further the Legislature requests the
Council to recommend legislative enactments as necessary from
time to time to implement the same.
Whereas, In accordance with the provisions of subsection (d), section six, article three-c, chapter five-a of the code of West
Virginia, 1931, as amended, the West Virginia Pharmaceutical Cost
Management Council has recommended the establishment of a pricing
schedule using or referencing FSS pricing as a benchmark for
prescription drug prices for the negotiation and purchase of brand
name drugs; and
Whereas, In accordance with the provisions of subsection (e),
section six, article three-c, chapter five-a of the code of West
Virginia, 1931, as amended, the adoption of a concurrent
resolution by the Legislature is required to authorize the
implementation of the FSS reference pricing schedule as a
benchmark for prescription drug prices for the negotiation and
purchase of brand name drugs and the strategic plan; therefore,
be it
Resolved by the Legislature of West Virginia:
That the Legislature hereby adopts the use or reference of
the FSS to establish a benchmark for prescription drug prices for
the negotiation and purchase of brand name drugs by the state of
West Virginia; and the Legislature authorizes the West Virginia
Pharmaceutical Cost Management Council to implement the FSS
pricing schedule as a benchmark for the negotiation and purchase
of brand name drugs and the strategic plan established in the
Reference Pricing Report submitted September 10, 2004, all in
accordance with the provisions of article three-c, chapter five-a of the code of West Virginia, 1931, as amended; and further the
Legislature requests the Council to recommend legislative
enactments as necessary from time to time to implement the same.